Early-cancer detection company Acuamark Diagnostics adds seasoned diagnostics industry executive Dr. Michael Hanbury to Board of Directors
Early-cancer detection company Acuamark Diagnostics adds industry veteran Haywood D. Cochrane to Board of Directors
Innovative luminaries are honored with prestigious recognition for academic inventors
Early-Cancer Detection Company Acuamark Diagnostics Adds David Weavil to Board of Directors.
Acuamark Diagnostics works to raise funds for its first round of clinical testing.
In its early stages, cancer is usually asymptomatic. Early detection is a complex challenge. Can a blood sample detect early signs? Feature Interview Of Dr. Francis Barany At Weill Cornell Medicine.
Acuamark Diagnostics welcomes diagnostics industry veteran Brian C. Carr to its Board of Directors.
iCareDx, Inc., a company focused on blood-based early detection of cancer changes its name to Acuamark Diagnostics, Inc.
iCareDx, Inc. assembles Advisory Board with team of thought leaders for blood-based early-cancer detection.